ANDSON BIOTECH INC.
ATLANTA, GA · Founded 2021 · CIK 0002017131 · Biotech · Private
An integrated platform for real-time mass spectrometry analysis of cell therapy manufacturing parameters and quality attributes
- Grants
- $303K
- 1 award
- Sector median: 1
- Raised
- $8.3M
- 2 Form D · Oct 2025
- 12 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $3,600,000 | |
| Federal grant | Department of Health and Human Services · Phase I · A Real-Time Mass Spectrometry Platform for In-Process Monitoring and Cell State Analysis | $302,671 | |
| Private capital raised | Form D · SEC | $4,735,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1462 | PridCor Therapeutics, LLC | — | $6.0M |
| 1463 | BLUESTEM BIOSCIENCES INC | — | $5.0M |
| 1464 | Lapix Therapeutics Inc. | — | $12M |
| 1465 | ANDSON BIOTECH INC. | — | $8.3M |
| 1466 | GC Therapeutics | — | — |
| 1467 | Endogenex, Inc. | — | $122M |
| 1468 | Nob Hill Therapeutics, Inc. | — | $2.2M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Mason ChilmonczykDirector · Executive Officer
- Glenn EpsteinDirector
- Andrei FedorovDirector
- Jim FilippiniExecutive Officer
- Thomas O'BrienDirector
- James RossDirector
Patents
- Systems And Methods For Sample Processingapplication
- Systems And Methods For Sample Processingapplication
- Systems And Methods For Sample Processingapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.